NCT06728410
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +6 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Roswell Park Cancer Institute Buffalo, New York, United States
Clinical trial condition
FGFR2 Gene Mutation
Explore clinical trials studying FGFR2 Gene Mutation. Study availability and eligibility vary by location and protocol.
4 public trials
1 recruiting study
FGFR2 Gene Mutation trial results
NCT04526106
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +10 more
- Locations
-
- The University of Alabama at Birmingham Birmingham, Alabama, United States
- Mayo Clinic Phoenix, Arizona, United States
- USC Norris Comprehensive Cancer Center Los Angeles, California, United States
- UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
Completed
Study to Evaluate the Efficacy and Safety of TT-00420 (Tinengotinib) in Cholangiocarcinoma
NCT04919642
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +7 more
- Locations
-
- Providence Cancer Center Anchorage, Alaska, United States
- City of Hope Duarte, California, United States
- University of California, Los Angeles, School of Medicine Santa Monica, California, United States
- USO Oncology Network- Rocky Mountain Cancer Centers Denver, Colorado, United States
NCT02965378
- Conditions
- FGFR1 Gene Amplification, FGFR1 Gene Mutation, FGFR2 Gene Amplification, +5 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States